Alphamab Oncology (9966.HK) - Quarterly Income Statement

Home
9966.HK
Financials

3.87 (HKD) • At close November 5, 2024

Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

	2024 Q2	2023 Q4	2023 Q2	2022 Q4	2022 Q2	2021 Q4	2021 Q2	2020 Q4	2020 Q2	2019 Q4	2019 Q2	2019 Q1	2018 Q4	2018 Q2	2018 Q1	2017 Q4	2017 Q2	2017 Q1	2016 Q4
Revenue Numbers are in millions	173.561	82.309	136.465	113.276	53.569	146.021	0	0	0	2.434	2.558	0	-1.081	0.346	0	0	0	0	0
Cost of Revenue Numbers are in millions	30.807	22.072	33.165	29.387	14.82	3.028	0	0	0	0	0	0	0	0	0	0	0	0	0
Gross Profit Numbers are in millions	142.754	60.237	103.3	83.889	38.749	142.993	0	0	0	2.434	2.558	0	-1.081	0.346	0	0	0	0	0
Gross Profit Ratio Numbers are in millions	0.823	0.732	0.757	0.741	0.723	0.979	0	0	0	1	1	0	1	1	0	0	0	0	0
Reseach & Development Expenses Numbers are in millions	194.531	212.843	194.681	251.839	216.399	249.414	231.947	197.517	133.724	110.902	55.752	41.664	39.031	26.577	16.402	16.402	13.305	13.305	13.305
General & Administrative Expenses Numbers are in millions	34.635	46.094	33.244	42.674	44.097	39.12	38.131	37.629	40.579	93.075	24.661	38.574	16.617	9.24	3.329	3.329	1.658	1.658	1.658
Selling & Marketing Expenses Numbers are in millions	0.086	0.038	0.187	0.004	0.165	-0.036	0.335	-0.02	0.02	0	0	0	0	0	0	0	0	0	0
SG&A Numbers are in millions	34.721	46.132	33.431	42.678	44.262	39.084	38.466	37.609	40.599	93.075	24.661	38.574	16.617	9.24	3.329	3.329	1.658	1.658	1.658
Other Expenses Numbers are in millions	0	0	0	0	0	0	0	0	0	0	-287.521	-287.521	-287.521	-56.815	-56.815	-56.815	-23.226	-23.226	-23.226
Operating Expenses Numbers are in millions	229.252	258.975	173.925	276.956	191.064	295.362	274.673	349.142	131.458	794.008	69.47	-207.284	100.542	100.272	-37.084	-37.084	-8.263	-8.263	-8.263
Operating Income Numbers are in millions	-86.498	-198.738	-124.625	-210.624	-221.747	-145.541	-270.078	-235.146	-174.303	-201.543	-77.855	-207.284	-56.729	-35.471	-37.084	-37.084	-8.263	-8.263	-8.263
Operating Income Ratio Numbers are in millions	-0.498	-2.415	-0.913	-1.859	-4.139	-0.997	0	0	0	-82.803	-30.436	0	52.478	-102.517	0	0	0	0	0
Total Other Income Expenses Net Numbers are in millions	41.602	28.007	84.763	32.211	74.438	0.488	2.714	-89.52	71.203	-572.412	19.07	-0.902	-45.862	-64.571	-13.574	-13.574	-7.943	-7.943	-7.943
Income Before Tax Numbers are in millions	-44.896	-170.731	-39.862	-178.413	-147.309	-145.053	-267.364	-324.666	-103.1	-773.955	-58.785	-208.185	-102.591	-100.042	-50.658	-50.658	-16.207	-16.207	-16.207
Income Before Tax Ratio Numbers are in millions	-0.259	-2.074	-0.292	-1.575	-2.75	-0.993	0	0	0	-317.977	-22.981	0	94.904	-289.139	0	0	0	0	0
Income Tax Expense Numbers are in millions	0.086	0.038	0	0	0	0	0	0	0	0	0.902	0.902	0.902	0.377	0.377	0.377	0.002	0.002	0.002
Net Income Numbers are in millions	-44.896	-170.731	-39.862	-178.413	-147.309	-145.053	-267.364	-324.666	-103.1	-773.955	-58.785	-209.087	-97.892	-51.951	-51.035	-51.035	-16.209	-16.209	-16.209
Net Income Ratio Numbers are in millions	-0.259	-2.074	-0.292	-1.575	-2.75	-0.993	0	0	0	-317.977	-22.981	0	90.557	-150.147	0	0	0	0	0
EPS Numbers are in millions	-0.05	-0.18	-0.042	-0.19	-0.16	-0.15	-0.29	-0.35	-0.11	-1.39	-0.12	-0.39	-0.21	-0.21	-0.057	-0.057	-0.018	-0.018	-0.018
EPS Diluted Numbers are in millions	-0.047	-0.18	-0.042	-0.19	-0.16	-0.15	-0.29	-0.35	-0.11	-1.39	-0.088	-0.39	-0.21	-0.21	-0.057	-0.057	-0.018	-0.018	-0.018
EBITDA Numbers are in millions	-55.627	-168.52	-99.021	-186.006	-205.823	-130.605	-256.493	-224.713	-165.756	-200.059	-77.511	-204.34	-56.52	-35.414	-35.444	-35.444	-8.135	-8.135	-8.135
EBITDA Ratio Numbers are in millions	-0.321	-2.047	-0.726	-1.642	-3.842	-0.894	0	0	0	-82.194	-30.301	0	52.285	-102.353	0	0	0	0	0

Alphamab Oncology

HKEX:9966.HK Add to watchlist

HKEX:9966.HK